Literature DB >> 7532596

Systemic production of foreign peptides on the particle surface of tobacco mosaic virus.

Y Sugiyama1, H Hamamoto, S Takemoto, Y Watanabe, Y Okada.   

Abstract

By using a new tobacco mosaic virus (TMV) vector [Hamamoto, H., et al. (1993) Bio/Technology 11, 930-932], we have constructed TMV particles which present three different kinds of epitopes, two of them from influenza virus hemagglutinin (HA), and one from human immunodeficiency virus type I (HIV-I) envelope protein, on the surface of the particles. Each of these TMV particles reacted with each anti-peptide antiserum. These results suggest that this TMV vector can be used as an antigen presentation system.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7532596     DOI： 10.1016/0014-5793(95)00054-d

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


  24 in total

Review 1.  Historical overview of research on the tobacco mosaic virus genome: genome organization, infectivity and gene manipulation.

Authors:  Y Okada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-03-29       Impact factor: 6.237

2.  Identification of immunogenic hot spots within plum pox potyvirus capsid protein for efficient antigen presentation.

Authors:  M Rosario Fernández-Fernández; Jorge L Martínez-Torrecuadrada; Fernando Roncal; Elvira Domínguez; Juan Antonio García
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Assembly and movement of a plant virus carrying a green fluorescent protein overcoat.

Authors:  S S Cruz; S Chapman; A G Roberts; I M Roberts; D A Prior; K J Oparka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 4.  Virus-based nanoparticles as platform technologies for modern vaccines.

Authors:  Karin L Lee; Richard M Twyman; Steven Fiering; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-19

5.  Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A.

Authors:  Stefan Werner; Sylvestre Marillonnet; Gerd Hause; Victor Klimyuk; Yuri Gleba
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

6.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

Review 7.  Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy.

Authors:  Kannan Badri Narayanan; Sung Soo Han
Journal:  Virus Genes       Date:  2018-07-14       Impact factor: 2.332

8.  Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope.

Authors:  M Koo; M Bendahmane; G A Lettieri; A D Paoletti; T E Lane; J H Fitchen; M J Buchmeier; R N Beachy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 9.  Genetic elements of plant viruses as tools for genetic engineering.

Authors:  A R Mushegian; R J Shepherd
Journal:  Microbiol Rev       Date:  1995-12

Review 10.  Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study.

Authors:  Carla Marusic; Alessandro Vitale; Emanuela Pedrazzini; Marcello Donini; Lorenzo Frigerio; Ralph Bock; Philip J Dix; Matthew S McCabe; Michele Bellucci; Eugenio Benvenuto
Journal:  Transgenic Res       Date:  2009-01-25       Impact factor: 2.788
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.